Boston Scientific tops expectations with 53% sales growth over 2020 | Fierce Biotech.
Is Boston Scientific a good stock to buy?
Valuation metrics show that Boston Scientific Corporation may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of BSX, demonstrate its potential to perform inline with the market. It currently has a Growth Score of D.
Is Boston Scientific profitable?
Marlborough medical device manufacturer Boston Scientific released its first quarterly report of 2022 on Wednesday, showing the company had profited $110 million for the quarter on $3 billion in revenue.
Is Boston Scientific still in business?
Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries.
Boston Scientific.
| Type | Public |
|---|---|
| Revenue | US$11.89 billion (2021) |
| Operating income | US$1.20 billion (2021) |
| Net income | US$1.04 billion (2021) |
| Total assets | US$32.23 billion (2021) |
Who are Boston Scientific competitors?
Boston Scientific competitors include Johnson & Johnson, Medtronic, Abbott, Biosense Webster and Cook Medical.
Is Boston Scientific buy or sell?
Boston Scientific has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.
Is Stryker buying Boston Scientific?
28 /PRNewswire-FirstCall/ — Boston Scientific Corporation (NYSE: BSX) today announced the execution of a definitive agreement under which Stryker Corporation will acquire Boston Scientific’s Neurovascular business.
Is Medtronic better than Boston Scientific?
Boston Scientific is most highly rated for Compensation and benefits and Medtronic is most highly rated for Compensation and benefits.
Overall Rating.
| Overall Rating | 3.9 | 3.9 |
|---|---|---|
| Job security and advancement | 3.5 | 3.4 |
| Management | 3.5 | 3.4 |
| Culture | 3.8 | 3.6 |
Is Boston Scientific a big company?
CNBC and Just Capital have released their 2021 list of America’s top 100 JUST companies, and Boston Scientific ranked 50 out of nearly 1,000 companies, first among companies in the health care equipment and services industry and number one for workers and the environment in our industry.
Is Boston Scientific a good company to work for?
Glassdoor recently recognized Boston Scientific with an Employees’ Choice Best Places to Work in 2018. Glassdoor selects the Top 100 based solely on employee company reviews over the last year. Boston Scientific ranked 35 in Glassdoor’s U.S. large company category with an overall company rating of 4.4 out of 5.0.
Is Boston Scientific a Fortune 100 company?
Boston Scientific Named a 2021 Fortune World’s Most Admired Company.
Does Boston Scientific give bonuses?
For each Performance Year in which you are eligible to participate, you will be assigned a Target Annual Bonus, which will be a specified percentage of your annual base salary, determined based on your position.
Who bought Boston Scientific?
Guidant
Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion.
What companies does Boston Scientific own?
Boston Scientific Scimed, Inc. Cardiac Pacemakers, Inc. EndoChoice, Inc. EP Technologies, Inc.
How many employees does Boston Scientific employ?
Boston Scientific total number of employees in 2021 was 41,000, a 7.89% increase from 2020. Boston Scientific total number of employees in 2020 was 38,000, a 5.56% increase from 2019. Boston Scientific total number of employees in 2019 was 36,000, a 12.5% increase from 2018.
What products does Boston Scientific make?
Implanted Devices
- Implanted Devices.
- Coronary Stents.
- Cardiac Resynchronization Therapy (CRT) Devices.
- Deep Brain Stimulation (DBS) Systems.
- Defibrillators (ICDs)
- LATITUDE™ Home Monitoring System.
- The TAVR Procedure.
- Pacemakers.
Does Boston Scientific stock pay dividends?
Boston Scientific Corporation does not currently pay dividends. As a result, the company also does not offer a dividend reinvestment program (DRIP).
What is Boston Dynamics stock symbol?
BSX
Boston Scientific Corporation Common Stock (BSX)
Is Boston Scientific part of Stryker?
Stryker bought Boston Scientific’s neurovascular unit in 2010 for $1.5 billion. Shares of Boston Scientific, which has a market value of about $44 billion, closed up 7.4 percent at $34.32, while Stryker shares fell 5.1 percent to close at $169.78.
Why is Boston Scientific?
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Our work is guided by core values that define Boston Scientific culture and empower our employees.
What does Stryker Neurovascular do?
Focused on advancing the practice of less invasive stroke therapies through its Complete Stroke Care solutions, Stryker is dedicated to providing best-in-class solutions for ischemic and hemorrhagic stroke care, education and clinical support.